Anti-Human IL1A Recombinant Antibody
-
产品编号
YR1369
-
别名
科研级 Bermekimab (贝迈奇单抗 ), Anti-IL1A Recombinant Antibody, Research Grade Bermekimab
-
规格
- 1mg
- 5mg
Alias | 科研级 Bermekimab (贝迈奇单抗 ), Anti-IL1A Recombinant Antibody, Research Grade Bermekimab |
Catalog Number | YR1369 |
Molecular Name | Bermekimab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Bermekimab[1] (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A). As of March 2017, bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis. |
CAS Number | 1401965-15-8 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IL1A[Homo sapiens] |